© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Multiple Sclerosis
New Brain Signal Technique Could Lead to Personalized Medicine in MS
November 09, 2022
Brain imaging technique may shed light on the clinical-radiological paradox of multiple sclerosis: structural damage in the brain related to the disease does not necessarily predict clinical disability.
Obesity May Be Associated With More Disabling MS
November 08, 2022
Research has linked obesity to an increased risk of getting multiple sclerosis. This German study examined whether there is a link between obesity and severity of the disease.
Smartphone Tapping Speed New Tool in Assessing MS, Study Finds
November 07, 2022
A small, preliminary study suggests that multiple sclerosis patients might be monitored based on the speed for their smartphone use.
Aerobic Exercise Eases MS Condition, Study Shows
October 10, 2022
Findings may support the development of an aerobic exercise training intervention for people with multiple sclerosis (MS) who present with MS-related thalamic atrophy.
Machine Learning Predicts MS Mental Health During Stay-at-Home Orders
October 10, 2022
A Carnegie Mellon researcher and colleagues used data from smartphones and fitness trackers to build machine learning models to predict depression, fatigue, poor sleep quality and worsening multiple sclerosis symptoms.
Kesimpta Cost-Effective MS Treatment, Says Canadian Study
October 09, 2022
A Novartis-funded analysis gives the Novaritis MS drug the nod based on a model using efficacy and safety data.
Healthcare Spending May Help Explain the Association MS and Latitude: Study
September 08, 2022
The link between higher multiple sclerosis rates and distance from the equator has commonly been explained by vitamin D levels. A new analysis from Johns Hopkins researchers suggests the association may also be linked to healthcare spending and the resources needed to diagnose disease.
Nurse Practitioner-led Care Improved Depression, Anxiety in People with MS
September 05, 2022
Research conducted in Canada suggests that people with multiple sclerosis would benefit from being seen by nurse practitioners. However, secondary outcomes in the study did not improve among patients with access to nurse practitioner-led care.
COVID-19 Vaccination and People with MS: T Cells Boosted, Antibodies Not So Much
September 05, 2022
Research shows that patients with multiple sclerosis who have been treated with drugs that target CD20 B cells drugs, such as Ocrevus and Rituxan, tend to have a weak antibody response. But cellular immunity and T cells are activated. The results suggest a need for vaccines that boost T cells.
Biosimilar to Tysabri for Relapsing-Remitting MS Is On Its Way
August 05, 2022
Sandoz has filed an application for a biosimilar to the blockbuster multiple sclerosis drug. It is not clear when it will be on the market.